In her entire 41 years, Roe Van Epps had never been able to shovel snow because of the crippling effect of cystic fibrosis. Then came the experimental CF drug VX-770 and one day this winter following a blizzard, she cleared her entire driveway.
Her inspiring story, and the scientific road traveled by the CF Foundation and Vertex Pharmaceuticals to develop VX-770, is featured in a National Public Radio story today, in a blog called CommonHealth.
NPR chronicles the Foundation's successful approach to drug development. “The Cystic Fibrosis Foundation, founded in 1955, is held up by many as a model disease-fighting group that bridges between researchers, doctors, patients and donors in perpetual quest for a cure,” the story says, continuing: “Without the Foundation, everyone seems to agree, there would be no VX-770.”
Read the full NPR story about VX-770.
|
1 min read
Share this article
Topics
About the CF Foundation
|
CFTR Modulators
|
Our Research Approach
CF Foundation Grateful for Continued Access to Trikafta in Colorado After Prescription Drug Affordability Board’s Ruling
News |
2 min read
CF Foundation Invests Up to $3 Million in ViaNautis Bio to Explore a New Method to Deliver Genetic Therapies to People With CF
News |
2 min read
CF Foundation Formalizes Final Set of Recommendations From External Racial Justice Working Group
News |
4 min read
Stay up to date with The Foundation
Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.